Filing status
- Accounts due
- 31 December 2026
- Last accounts
- 31 December 2024
- Conf. stmt due
- 12 June 2027
- Last conf. stmt
- 29 May 2026
Altimmune UK Limited
- Incorporated
- 5 October 1992 (34 years)
- Previously known as
- Vaxin UK Limited (until 1 September 2015)Immune Targeting Systems (Its) Limited (until 11 March 2015)Xovax Limited (until 17 September 2003)Earlier: Nimstone Sales Limited
- Industry
- Research and experimental development on biotechnology (72110)
- Directors
- Gregory Lee WeaverAltimmune, Inc.
- Owned by
- Altimmune, Inc.
- Accounts type
- Small
- Region
- Yorkshire
- Address
- Central Square 5th Floor29 Wellington StreetLeedsLS1 4DL
Officers 2 active
Officer details are public data from the Companies House register.
Weaver, Gregory Lee
Director · Appointed 24 July 2026
American
Born March 1956 (70)
Altimmune, Inc.
Corporate Director · Appointed 4 June 2026
Officer history (31 former)
24 July 2026
Appointed Weaver, Gregory Lee as Director
4 June 2026
Appointed Altimmune, Inc. as Corporate Director
4 June 2026
Resigned Garg, Vipin, President as Director
30 November 2018
30 November 2018
Appointed Garg, Vipin, President as Director
8 May 2018
Resigned Czerepak, Elizabeth Adkins, Mrs. as Director
6 June 2017
Resigned Drutz, David, Dr as Director
6 June 2017
Resigned Brennan, Christine, Dr. as Director
6 June 2017
Resigned Pouletty, Philippe Jacques Michel as Director
6 June 2017
Resigned Hodges, Philip Lawton as Director
6 June 2017
Resigned Steen, Marten, Dr as Director
6 June 2017
Resigned Schäfer, Klaus Otto, Dr as Director
6 June 2017
Appointed Czerepak, Elizabeth Adkins, Mrs. as Director
8 September 2016
8 September 2016
Appointed Brennan, Christine, Dr. as Director
11 March 2015
11 March 2015
Appointed Drutz, David, Dr as Director
11 March 2015
Appointed Hodges, Philip Lawton as Director
11 March 2015
Appointed Schäfer, Klaus Otto, Dr as Director
10 March 2015
Resigned Chen, Benjamin, Dr as Director
10 March 2015
30 August 2012
Appointed Chen, Benjamin, Dr as Director
9 July 2012
Resigned Brown, Carlton Bradley as Director
4 May 2011
Appointed Steen, Marten, Dr as Director
4 May 2011
Resigned Gunterberg, Jacob Uno Stanley as Director
18 March 2011
8 April 2010
Resigned Becker, Martin Joseph as Director
8 April 2010
8 April 2010
Resigned Adams, Daniel Drysdale as Director
17 December 2009
Appointed Gunterberg, Jacob Uno Stanley as Director
17 December 2009
Resigned Persson, Gunnar Magnus Severus as Director
21 October 2009
Resigned Persson, Gunnar Magnus Severus as Director
21 October 2009
2 July 2009
Resigned Williams, Sandra as Secretary
26 February 2009
26 February 2009
Appointed Williams, Sandra as Secretary
11 December 2008
29 November 2007
28 June 2007
Appointed Pouletty, Philippe Jacques Michel as Director
28 June 2007
28 June 2007
Appointed Becker, Martin Joseph as Director
28 June 2007
Appointed Adams, Daniel Drysdale as Director
28 June 2007
Appointed Persson, Gunnar Magnus Severus as Director
28 June 2007
Appointed Persson, Gunnar Magnus Severus as Director
23 March 2007
1 June 2005
Resigned Sizer, Philip James Holden as Director
1 November 2004
Resigned Brown, Carlton Bradley as Secretary
10 August 2004
1 June 2004
19 July 2003
Appointed Brown, Carlton Bradley as Secretary
19 July 2003
Appointed Brown, Carlton Bradley as Director
19 July 2003
Appointed Sizer, Philip James Holden as Director
19 July 2003
18 July 2003
18 July 2003
Resigned Simpson, John Karl as Director
10 July 2003
4 April 1994
Appointed Simpson, John Karl as Director
5 October 1992
5 October 1992
5 October 1992
5 October 1992
5 October 1992
5 October 1992
Ownership 1 active
People and entities with significant control, from the Companies House PSC register
Altimmune, Inc.
Corporate entity · Notified 13 May 2021
Owns 75–100% of shares
Holds 75–100% of voting rights
Right to appoint and remove directors
Public Limited Company
Reg. no. Us202726770
Former controllers (3)
4 June 2026
Ceased President Vipin Garg — Has significant influence or control
30 November 2018
8 May 2018
Ceased Elizabeth Adkins Czerepak — Has significant influence or control
Financials
Balance sheet as at 31 December 2024 · small accounts
- Net Assets
- (£10,613,175)
- Cash
- £76,080
- Turnover
- £0
- Profit Before Tax
- (£4,370,799)
- Employees
- 2
- Debt Ratio
- 785%
- Current Ratio
- 0.1x
Trend
Turnover
Balance sheet detail
| 2024 | 2023 | |
|---|---|---|
| Fixed Assets | £0 | £0 |
| Current Assets | £1,550,387 | £3,271,742 |
| Debtors | £1,474,307 | £3,155,227 |
| Cash | £76,080 | £116,515 |
| Creditors (< 1 year) | £12,163,562 | £12,510,687 |
| Creditors (> 1 year) | £0 | £0 |
| Net Current Assets | (£10,613,175) | (£9,238,945) |
| Net Assets | (£10,613,175) | (£9,238,945) |
| Shareholder Funds | (£10,613,175) | (£9,238,945) |
| Turnover | £0 | £0 |
| Cost of Sales | £3,942,087 | £8,184,360 |
| Gross Profit | (£3,942,087) | (£8,184,360) |
| Admin Expenses | £436,168 | £233,232 |
| Operating Profit | (£4,378,255) | (£7,951,128) |
| Profit Before Tax | (£4,370,799) | (£7,951,076) |
| Tax | £403,222 | £1,071,025 |
| Profit for Period | (£3,967,577) | (£6,880,051) |
Filings
Filing history not loaded yet. See it on Companies House
Some other companies at this address
Other companies in this industry
Guildford
Macclesfield
Kidlington
Kidlington
Middlesex
By trade and location
Explore the largest companies
Need accounts figures, ownership or websites for thousands of companies? Bulk data & API →